StocksDiva Bio-Bin. FDA Target dates to Oct 29th. and chart links. http://investorshub.advfn.com/StocksDiva-Bio-Bin-16112/ 10/29/2012 Cornerstone Therapeutics Inc. CRTX CRTX 080 (NDA) FDA decision on CRTX 080 for treatment of hyponatremia http://stockcharts.com/h-sc/ui?s=CRTX&p=W&yr=0&mn=10&dy=0&id=p98537415266 10/27/2012 United Therapeutics Corp UTHR UT-15C Treprostinil Diethanolamine Sustained Release Tablets (NDA) FDA decision on Treprostinil for pulmonary arterial hypertension http://stockcharts.com/h-sc/ui?s=UTHR&p=W&yr=0&mn=10&dy=0&id=p19857067596 10/23/2012 Hyperion Therapeutics, Inc. HPTX Ravicti (NDA) FDA decision on Ravicti for treatment of urea cycle disorder http://stockcharts.com/h-sc/ui?s=HPTX&p=W&yr=0&mn=10&dy=0&id=p43085630433 10/21/2012 Impax Laboratories Inc IPXL IPX066 (NDA) FDA decision on IPX066 for treatment of idiopathic Parkinson's disease http://stockcharts.com/h-sc/ui?s=IPXL&p=W&yr=0&mn=10&dy=0&id=p69460166375 10/19/2012 Supernus Pharmaceuticals, Inc. SUPN SPN-804 (NDA) FDA decision on SPN-804 for epilepsy http://stockcharts.com/h-sc/ui?s=SUPN&p=W&yr=0&mn=10&dy=0&id=p70809143664 10/16/2012 Santarus Inc. SNTS UCERIS (NDA) FDA decision on UCERIS for induction of remission of mild to moderate active ulcerative colitis http://stockcharts.com/h-sc/ui?s=SNTS&p=W&yr=0&mn=10&dy=0&id=p15528194029